Aurora Spine Corporation
ASAPF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $16,782 | $17,031 | $19,095 | $21,648 |
| - Cash | $666 | $581 | $489 | $825 |
| + Debt | $3,587 | $3,633 | $3,678 | $2,564 |
| Enterprise Value | $19,703 | $20,083 | $22,284 | $23,387 |
| Revenue | $4,382 | $4,497 | $4,417 | $4,570 |
| % Growth | -2.6% | 1.8% | -3.3% | – |
| Gross Profit | $1,116 | $2,799 | $2,563 | $1,062 |
| % Margin | 25.5% | 62.2% | 58% | 23.2% |
| EBITDA | $140 | $123 | -$39 | -$337 |
| % Margin | 3.2% | 2.7% | -0.9% | -7.4% |
| Net Income | -$140 | -$199 | -$350 | -$634 |
| % Margin | -3.2% | -4.4% | -7.9% | -13.9% |
| EPS Diluted | -0.002 | -0.003 | -0.005 | -0.008 |
| % Growth | 30.8% | 42.2% | 45.1% | – |
| Operating Cash Flow | $343 | $200 | -$162 | $176 |
| Capital Expenditures | -$203 | -$54 | -$192 | $6 |
| Free Cash Flow | $140 | $146 | -$354 | $182 |